- Report
- December 2020
- 83 Pages
From €2024EUR$2,100USD£1,741GBP
€2891EUR$3,000USD£2,487GBP
- Report
- November 2020
- 195 Pages
Global
From €3069EUR$3,185USD£2,640GBP
€4384EUR$4,550USD£3,771GBP
- Report
- September 2021
- 100 Pages
Global
From €4336EUR$4,500USD£3,730GBP
- Report
- August 2022
United States
From €1869EUR$1,940USD£1,608GBP
- Report
- August 2022
Global
From €954EUR$990USD£821GBP
- Report
- August 2021
Global
From €3845EUR$3,990USD£3,307GBP
- Report
- August 2021
Europe
From €3295EUR$3,420USD£2,835GBP
- Report
- February 2021
Global
From €2852EUR$2,960USD£2,453GBP
- Report
- April 2022
- 560 Pages
Global
From €4818EUR$5,000USD£4,144GBP
- Clinical Trials
- February 2020
- 437 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Report
- November 2018
- 106 Pages
Global
From €10595EUR$10,995USD£9,113GBP
- Drug Pipelines
- September 2020
- 193 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- September 2020
- 79 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Report
- January 2020
- 100 Pages
Global
From €4620EUR$4,795USD£3,974GBP
- Report
- May 2022
- 163 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Report
- August 2022
- 324 Pages
Global
From €5868EUR$6,090USD£5,048GBP
- Report
- April 2023
- 160 Pages
Global
From €5781EUR$5,999USD£4,972GBP
The Opioid Addiction market is a subset of the Addiction Disorders Drugs market, which includes medications used to treat substance use disorders. Opioid Addiction medications are used to treat opioid use disorder, a condition characterized by compulsive opioid use despite negative consequences. These medications work by blocking the effects of opioids, reducing cravings, and helping to prevent relapse. Common medications used to treat opioid addiction include buprenorphine, methadone, and naltrexone.
The Opioid Addiction market is highly regulated, with strict guidelines for prescribing and dispensing medications. In addition, many of these medications require special training and certification for healthcare providers.
Companies in the Opioid Addiction market include Reckitt Benckiser, Indivior, Orexo, and Braeburn Pharmaceuticals. Show Less Read more